Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 10, 2011

Premium

Response Genetics said this week that it has named Christine Meda as president of the company.

Kathleen Danenberg, who held the position previously, will continue to serve as CEO of the company.

Meda was most recently president and CEO of Arcxis Biotechnologies. She also founded and is president of RxDxLink; and has served as president and COO of Diamics. Prior to that, Meda held various positions at Roche Molecular Diagnostics, including vice president of business development and vice president of women's health.


BioNanomatrix has appointed Erik Holmlin as CEO, president, and director, succeeding Edward Erickson, who is now CEO at Saladax Biomedical.

Prior to joining BioNanomatrix, Holmlin served as CEO and president of GenVault, which merged with IntegenX last month. Prior to that he was chief commercial officer at Exiqon, where he was responsible for global sales, marketing, and clinical affairs for oncology services. In 2001, he founded molecular diagnostics company GeneOhm Sciences, which was acquired by Becton Dickinson in 2006.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.